New study aims to personalize care for tiny hearts
NCT ID NCT07374146
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study focuses on extremely preterm infants (born before 32 weeks) who have a heart condition called hsPDA. Researchers will collect blood samples and health data to create a model that predicts which infants need treatment. They are also developing a targeted drug-delivery system to treat the condition more precisely. The goal is to improve care for these vulnerable babies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMODYNAMICALLY SIGNIFICANT PATENT DUCTUS ARTERIOSUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.